Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board177
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity156
Differential immune responses behind different celiac disease manifestations90
Cellular stress and macrophage activation80
Exploiting antifungal immunity in the clinical context66
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells62
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer60
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi59
Pyroptosis modulation by bacterial effector proteins55
Local and Cell-intrinsic complement: The new player in cancer progression52
Aging of lymphoid stromal architecture impacts immune responses50
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity49
Editorial Board44
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges44
Resolving inflammatory links between myocardial infarction and vascular dementia44
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)42
Microbial metabolites and immunotherapy: Basic rationale and clinical indications42
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity41
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?40
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease39
Immunity to pathogenic fungi in the eye39
Pyroptosis: A road to next-generation cancer immunotherapy37
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity36
Pyroptosis and the cellular consequences of gasdermin pores35
Interplay between the complement system and other immune pathways in the tumor microenvironment34
The noncanonical inflammasome-induced pyroptosis and septic shock34
Western diet influences on microbiome and carcinogenesis33
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment33
Introduction to the special issue: Neutrophils in the tumor microenvironment31
Cellular and molecular diversity in spondyloarthritis30
Immunity to fungi: Editorial overview30
Specialized pro-resolving mediators as modulators of immune responses29
The paradox of aging: Aging-related shifts in T cell function and metabolism29
Adaptive NK cell response to human cytomegalovirus: Facts and open issues28
The evolving biology of cross-presentation28
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets27
Neuroimmune interactions between itch neurons and skin microbes25
Autoimmune diabetes and targets for immunomodulation25
TREM2: A new player in the tumor microenvironment24
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases24
Antigen discovery for the development of cancer immunotherapy23
Recent developments in C3-targeted complement therapeutics23
Sialic acid and Siglec receptors in tumor immunity and immunotherapy22
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy22
The dual role of neutrophils in cancer22
Thymus aging and immune reconstitution, progresses and challenges22
Introduction to the Special Issue: Nutrition, microbiota and immunity21
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases21
T cell control of SARS-CoV-2: When, which, and where?21
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic20
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs20
T cell fate decisions during memory cell generation with aging20
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy19
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?19
Targeting the tissue-complosome for curbing inflammatory disease19
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders19
Publisher's note: Welcome Prof. Guido Kroemer19
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity19
Better safe than sorry: Naive T-cell dynamics in healthy ageing18
Editorial Board18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells18
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy17
The glycoimmune landscape in health and disease17
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice17
Proteostasis in T cell aging17
Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease16
The complement system in clinical oncology: Applications, limitations and challenges16
Cellular and molecular heterogeneity in systemic lupus erythematosus16
Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis16
Natural killer cell responses to human oncogenic γ-herpesvirus infections16
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging15
The gut-enthesis axis and the pathogenesis of Spondyloarthritis15
Identification of T cell antigens in the 21st century, as difficult as ever15
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review15
Harnessing complement biomarkers for precision cancer care14
The multisensory regulation of unconventional T cell homeostasis14
Global aspects of celiac disease and food allergy14
Epigenetic and transcriptional control of gasdermins14
Human thymus in health and disease: Recent advances in diagnosis and biology14
Emerging opportunities for C3 inhibition in the eye14
Impact of cancer cell-intrinsic features on neutrophil behavior13
Corrigendum to “Nanoalum adjuvanted vaccines: Small details make a big difference” [Semin. Immunol. 56 (2021) 101544]13
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches13
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics13
A major mechanism for immunomodulation: Dietary fibres and acid metabolites13
Unconventional protein secretion by gasdermin pores13
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions13
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation12
Siglecs as modulators of macrophage phenotype and function12
Pyroptosis-induced inflammation and tissue damage12
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases12
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC12
Durability of immune responses to SARS-CoV-2 infection and vaccination12
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond12
Microbial gasdermins: More than a billion years of pyroptotic-like cell death12
Systems analysis of innate and adaptive immunity in Long COVID12
The role of ILC subsets in cancer12
Reparative inflammation in multiple sclerosis11
Current insights in mouse iNKT and MAIT cell development using single cell transcriptomics data11
Integrating immunopeptidome analysis for the design and development of cancer vaccines10
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond10
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies10
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease10
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation10
Neutrophil metabolism in the cancer context10
Editorial Board10
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas10
Regulatory T cells in allergic inflammation10
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives9
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions9
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function9
Publisher’s Note: A change in leadership9
Complement regulation in tumor immune evasion9
Systems analysis of human innate immunity in COVID-199
Galectins and Host–Pathogen Interactions: The roles in viral infections9
The gut-brain vascular axis in neuroinflammation9
Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions8
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences8
The role of neutrophil extracellular traps in cancer progression and metastasis8
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging8
The role of sialoglycans in modulating dendritic cell function and tumour immunity8
To die or not to die: Gasdermins in intestinal health and disease8
The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients8
Immunity to fungi in the lung8
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies8
Complement component C3: A structural perspective and potential therapeutic implications8
0.05069899559021